Organizations Filed Purposes:
HEALTHCARE. VASCULAR CURES ADVANCES PATIENT-CENTERED RESEARCH, CATALYZESBREAKTHROUGH COLLABORATIONS AND EMPOWERS PEOPLE IN THEIR VASCULAR HEALTHJOURNEY.
Vascular Cures is a leader in break- through innovations to improve the lives of patients with vascular disease. The organization is transforming the vascular care-to-cure continuum, driving novel collaborations in patient-centered research and (continued on page 2)
THE VASCULAR CURES RESEARCH NETWORK SUPPORTS NOVEL COLLABORATIONS AND ADVANCES HIGH-IMPACT PROJECTS THROUGH NATIONAL MULTI-STAKEHOLDER INNOVATION SUMMITS AND PATIENT-CENTERED RESEARCH GRANTS. THE VASCULAR CURES RESEARCH NETWORK BUILDS ON COLLABORATION NOT COMPETITION TO ACCELERATE RESULTS. WE HAVE INVESTED $15 MILLION IN PATIENT-CENTERED RESEARCH TO DATE.
THE WYLIE SCHOLAR PROGRAM GOAL IS TO CREATE A PIPELINE OF INNOVATORS IN PATIENT-CENTERED RESEARCH AND CARE. THIS IS A THREE-YEAR CAREER DEVELOPMENT GRANT OF $150,000 TO OUTSTANDING YOUNG VASCULAR SURGEON-SCIENTISTS WHO COMBINE THEIR CLINICAL PRACTICE WITH INNOVATIVE RESEARCH. ONE AWARD IS GIVEN PER YEAR, AND 20 GRANTS HAVE BEEN AWARDED SINCE 1996; RESEARCH SUPPORTED BY THIS GRANT ALLOWS THEM TO COMPETE FOR FURTHER FUNDING FROM GOVERNMENT AND OTHER ORGANIZATIONS - AND RESULTS HAVE BEEN EXTRAORDINARY. ON AVERAGE, WYLIE SCHOLARS GO ON TO RECEIVE 25 TIMES THEIR ORIGINAL FUNDING.
EDUCATION AND COMMUNITY AWARENESS PROGRAMS ARE PURSUED THROUGHOUT THE YEAR, TO BROADEN THE AWARENESS OF THE RISKS, CONSEQUENCES AND NEW TREATMENTS FOR VASCULAR DISEASE. WE EMPHASIZE EMPOWERMENT AND SHARED DECISION-MAKING BEST PRACTICES, HELPING TO ENSURE THAT PATIENTS WITH VASCULAR DISEASE AND THEIR FAMILIES ARE EQUIPPED WITH THE KNOWLEDGE TO MAKE INFORMED DECISIONS ABOUT THEIR HEALTH CARE. WE HAVE A SPECIFIC FOCUS ON PREVENTION AND MAKING RESOURCES ACCESSIBLE TO VULNERABLE POPULATIONS AND COMMUNITIES. OUR PATIENTS AS PARTNERS PROGRAM PROMOTES AND FACILITATES THE INCLUSION OF PATIENT ADVOCATES IN NATIONAL RESEARCH PROJECTS AND CARE INITIATIVES, BRINGING THE PATIENT VOICE TO THE TABLE EVERYWHERE DECISIONS ARE BEING MADE IN VASCULAR HEALTHCARE.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Megan Patterson | CEO | 40 | $137,168 |
| Wendy R Hitchcock | Director | 2 | $28,108 |
| Margaret Wong | CEO | 2 | $0 |
| Julie Lawrence | Director | 2 | $0 |
| Bob Kain | Director | 2 | $0 |
| Kevin Heath | Director | 2 | $0 |
| Douglas Grey Md | Director | 2 | $0 |
| Michael Conte Md | Director | 2 | $0 |
| Lilia Coburn | Director | 2 | $0 |
| David Rae | Treasurer | 2 | $0 |
| Edward Yu | Board Chair | 2 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202140839349300524_public.xml